Annual Meeting Archives
2016
Category:
Comparative Pharmacokinetics in Preclinical Sciences
Institutions:
(1) Simcyp, United Kingdom
Category:
Local Drug Delivery
Institutions:
(1) College of Pharmacy/Gachon University, Korea
Category:
Local Drug Delivery
Institutions:
(1) Department of Internal Medicine III, University Hospital Munich, LMU, Munich, Germany; (2) Department of Pharmacy, Pharmaceutical Technology & Biopharmaceutics, LMU, Munich, Germany
Category:
Tissue Engineering
Institutions:
(1) Applied Physics Program, University of Michigan, U.S.A.; (2) Department of Radiology, University of Michigan Health System, U.S.A.; (3) School of Dentistry, University of Michigan, U.S.A.; (4) Department of Biomedical Engineering, University of Michig
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) University of Auckland, New Zealand; (2) School of Pharmacy, University of Auckland, New Zealand; (3) Auckland Cancer Society Research Centre, University of Aucklanfd, New Zealand
Category:
Preclinical Science Challenges to Drug Delivery
Institutions:
(1) University of Washington, U.S.A.
Category:
Oral Delivery
Institutions:
(1) INEB, Portugal; (2) Faculty of Pharmacy, University of Helsinki, Finland
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) The Hebrew University of Jerusalem, Israel
Category:
Taking Stock of Progress and Challenges in Drug Delivery and Targeting
Institutions:
(1) University of Toronto, Canada
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) LMU München, Germany; (2) Veyx Pharma GmbH, Germany; (3) Universität Leipzig, Germany
Category:
Oral Delivery
Institutions:
(1) Department of Pharmaceutical Sciences University of Basel, Switzerland; (2) Omya International AG, Switzerland
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) UC Davis, Biological and Agricultural Engineering, U.S.A.; (2) UC Davis, Biological and Agricultural Engineering and Food Science and Technology, U.S.A.
Category:
Oral Delivery
Institutions:
(1) MilliporeSigma, Germany
Category:
Manufacture, Characterization, Stability, and Regulatory Aspects
Institutions:
(1) Ruhr University Bochum, Germany; (2) Fraunhofer Institute UMSICHT, Germany
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) University of Washington, U.S.A.
Category:
Tissue Engineering
Institutions:
(1) National Taiwan University, Taiwan
Category:
Local Drug Delivery
Institutions:
(1) School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand; (2) Department of Surgery, Middlemore Hospital, Faculty of Medicine and Health Sciences, University of Auckland,, New Zealand; (3) School of Medicine, Fac
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) University Medical Center Utrecht, Netherlands
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) West China School of Pharmacy, Sichuan University, China
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) Gowan Company, U.S.A.
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) University of Vermont, U.S.A.
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Oregon State University, U.S.A.
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) Drugs Technology LLC, Russia; (2) D.Mendeleyev University of Chemical Technology of Russia, Russia; (3) St. Petersburg Institute of Pharmacy, Russia
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) University of Maryland - College Park, U.S.A.
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) AstraZeneca R&D Mölndal, Sweden; (2) EPFL Lausanne, Switzerland; (3) Iowa state University, U.S.A.